Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer
Clinical trial NCT03521570 · COMPLETED
Trial details
- NCT number
- NCT03521570
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-28
- Primary completion
- 2022-07-25
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.